Partner News | Published: Wednesday, October 29, 2025
MedAxiom, the cardiovascular community’s premier source for organizational performance solutions, announced a new industry partnership with Kestra Medical Technologies, a wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using therapeutic intervention technologies that are intuitive, intelligent, and connected. This collaboration will connect the MedAxiom community with Kestra’s innovative Cardiac Recovery System® platform, offering clinicians new tools to support patients at risk for sudden cardiac arrest (SCA).
Kestra’s ASSURE® system is a wearable cardioverter defibrillator (WCD) designed for comfort and clinical performance. Available in seven sizes and two wearable styles, the system delivers strong patient compliance¹ and significantly fewer false alarms than other wearable defibrillators.*1,2 Real-world evidence shows the system delivers actionable insights, helping care teams detect meaningful cardiac events and support SCA risk management and recovery.3,4
“Partnering with MedAxiom brings Kestra into a powerful community of cardiovascular innovators working to transform care,” said Debra Schotz, senior vice president of marketing at Kestra Medical Technologies. “Together, we can amplify awareness of the Cardiac Recovery System platform and demonstrate how actionable insights can shape strategies for sudden cardiac arrest risk management.”
Kestra’s connected services include Heart Alert™ service for provider notification of potential cardiac events and ASSURE Assist® service, which connects patients to emergency services after a shock – offering timely support and extending the reach of care teams.
“Kestra’s emphasis on patient comfort, reliable event detection, and seamless care coordination creates a first-rate experience for patients and care teams alike. Working with Kestra will help MedAxiom member programs to implement and improve their WCD capabilities, which aligns with our mission to transform cardiovascular care and improve heart health for all,” said Joe Sasson, PhD, MedAxiom’s executive vice president of Ventures and chief commercial officer. “We are excited to welcome Kestra as a new partner and look forward to sharing their insights with MedAxiom members and the larger cardiovascular community.”
About MedAxiom
MedAxiom, an American College of Cardiology Company, is the cardiovascular community’s premier source for organizational performance solutions. MedAxiom is transforming cardiovascular care by combining the knowledge and power of hundreds of cardiovascular organization members, thousands of administrators, clinicians and revenue cycle experts, and dozens of industry partners. Through the delivery of proprietary tools, smart data and proven strategies, MedAxiom helps cardiovascular organizations achieve the Quadruple Aim of better outcomes, lower costs, improved patient experience and improved clinician experience. For more information, visit medaxiom.com.
About Kestra Medical Technologies
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit kestramedical.com
*Disclaimer: A controlled, head-to-head study evaluating the comparative performance of these devices has not been done.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.
